查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2027752

全球視網膜手術設備市場：按產品、應用、最終用戶、國家和公司分析（2026-2034 年）

Retinal Surgery Devices Market Report by Product, Application, End User, Countries and Company Analysis 2026-2034
出版日期: | 出版商: Renub Research | 英文 200 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

視網膜手術設備市場規模及預測（2026-2034年）

全球視網膜手術設備市場規模預計將從2025年的24.7億美元成長至2034年的47.5億美元，2026年至2034年的年複合成長率預計為7.54%。對先進眼科治療需求的成長、視網膜疾病盛行率的上升以及微創手術技術的普及加速市場擴張。影像技術、玻璃體切除系統和手術器械方面的技術創新也進一步推動了全球醫療保健系統市場的成長。

視網膜手術設備市場概覽

由於全球患有糖尿病視網膜病變、老齡化黃斑部病變和視網膜裂孔等需要先進手術干預的患者數量不斷增加，視網膜手術設備市場擴張。玻璃體切除平台、照明系統和高解析度成像技術的持續改進進一步加速了其應用。醫療專業人員正轉向微創眼科手術，這推動了對高精度、高效率設備的需求。眼科研究投入的增加、新產品的推出以及監管核准的通過也促進了市場成長。此外，新興市場眼科醫療服務的普及以及數位診斷和即時視覺化工具的整合，也增強了視網膜手術設備市場的長期前景。

視網膜手術設備市場的成長促進因素

快速的技術創新和策略收購

技術創新仍然是視網膜手術設備市場最重要的驅動力之一。新一代玻璃體切除系統、增強型視覺化平台和人工智慧驅動的診斷技術提升視網膜手術的精確度和效率。各公司不斷透過策略性收購來強化產品組合，加速產品研發並拓展全球業務。Carl Zeiss Meditec AG於2024年4月完成對Dutch Ophthalmic Research Center的收購就是一個典型的例子。此舉增強了該公司在眼科領域的產品組合、工作流程解決方案和創新能力，並將推動更全面的手術平台的開發。此次擴張將使製造商能夠提供更全面的視網膜治療方案，改善外科醫生的操作體驗和患者的治療效果。在全球對先進眼科護理需求不斷成長的背景下，這些技術進步和企業整合推動市場的持續成長。

先進外科手術平台的推廣和核准

視網膜手術設備市場的主要成長要素之一是獲得監管核准批准的先進手術平台的日益普及。醫院和眼科中心越來越依賴能夠提供更高精度、更安全的液體管理和更清晰視野的技術。2024年6月，Alcon的Unity VCS和Unity CS系統獲得了FDA 510（k）批准，這兩款系統是其新一代Unity產品組合的一部分，專為白內障和玻璃體視網膜手術而設計。這些平台提高了工作流程效率，在2025年後實現更廣泛的商業化。此類核准加速了產品的普及，並幫助醫療機構提升手術能力。隨著眼科專業人員致力於改善治療效果和縮短恢復時間，獲得監管部門核准的先進系統的整合顯著提升市場需求，並鞏固整體市場成長動力。

人們越來越關注微創眼科治療

患者希望更快康復並減少術後併發症，這促使微創視網膜手術成為推動該領域的關鍵因素之一。外科醫生擴大使用微創器械、先進的液體控制技術和雷射解決方案，以更精確地控制精細的視網膜手術。市場領導者的策略擴張進一步加速了微創技術的創新。2024年7月，Alcon宣布收購Belkin Vision，透過引進直接選擇性雷射小梁網整型術（SLT）擴展了其青光眼治療產品組合。此次收購增強了Alcon在能量型眼科解決方案方面的能力，因為SLT在治療開放性青光眼和高眼壓症方面展現出卓越的臨床療效和成本效益。手術技術的進步以及青光眼和視網膜護理的融合推動微創手術的普及，並促進全球市場的強勁成長。

本報告研究了全球視網膜手術設備市場，深入分析了成長促進因素和挑戰、細分市場分析以及主要企業分析。

目錄

第1章 引言

第2章 研究與調查方法

第3章 執行摘要

第4章 市場動態

  • 成長促進因素
  • 課題

第5章 全球視網膜手術設備市場

  • 市場實績
  • 市場預測

第6章 市場佔有率分析

  • 依產品
  • 依用途
  • 依最終用戶
  • 依國家

第7章 產品

  • 玻璃體切除機
    • 市場實績
    • 市場預測
  • 玻璃體切除套件
    • 市場實績
    • 市場預測
  • 手術器械
    • 市場實績
    • 市場預測
  • 顯微鏡照明設備
    • 市場實績
    • 市場預測
  • 視網膜雷射設備
    • 市場實績
    • 市場預測
  • 其他
    • 市場實績
    • 市場預測

第8章 應用

  • 糖尿病視網膜病變
    • 市場實績
    • 市場預測
  • 視網膜剝離
    • 市場實績
    • 市場預測
  • 視網膜前膜
    • 市場實績
    • 市場預測
  • 黃斑裂孔
    • 市場實績
    • 市場預測
  • 其他
    • 市場實績
    • 市場預測

第9章 最終用戶

  • 醫院
    • 市場實績
    • 市場預測
  • 眼科診所
    • 市場實績
    • 市場預測
  • 其他
    • 市場實績
    • 市場預測

第10章 國家

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 英國
    • 比利時
    • 荷蘭
    • 土耳其
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 泰國
    • 馬來西亞
    • 印尼
    • 紐西蘭
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第11章 波特五力分析

第12章 SWOT 分析

第13章 主要企業分析

  • Topcon Corporation
  • Alcon AG
  • Carl Zeiss
  • Bausch Health Companies Inc
  • Iridex Corporation
  • Escalon Medicals
  • Quantel Medical
  • Rhein Medical, Inc
簡介目錄

Retinal Surgery Device Market Size and Forecast 2026-2034

Retinal Surgery Device Market is expected to reach US$ 4.75 billion by 2034 from US$ 2.47 billion in 2025, with a CAGR of 7.54% from 2026 to 2034. Growing demand for advanced ophthalmic treatments, rising prevalence of retinal disorders, and increased adoption of minimally invasive surgical techniques are accelerating market expansion. Technological innovations in imaging, vitrectomy systems, and surgical tools further strengthen market growth across global healthcare systems.

Retinal Surgery Device Industry Overview

Retinal surgery devices are specialized ophthalmic instruments and systems designed to diagnose, treat, and repair disorders affecting the retina, such as retinal detachment, macular holes, diabetic retinopathy, and vitreous hemorrhage. These devices include vitrectomy machines, illumination systems, lasers, surgical instruments, and visualization technologies that support precise, minimally invasive procedures. They help surgeons access the delicate retinal layers with greater accuracy and safety, improving surgical outcomes and reducing recovery time. Advances in micro-instrumentation, fluidics control, and high-definition imaging have significantly enhanced retinal surgeries, making these devices essential tools in modern ophthalmology practices and specialized eye care centers worldwide.

The retinal surgery device market is expanding due to increasing global cases of diabetic retinopathy, age-related macular degeneration, and retinal tears, all requiring advanced surgical intervention. Continuous improvements in vitrectomy platforms, illumination systems, and high-resolution imaging technologies further accelerate adoption. Healthcare providers are transitioning toward minimally invasive ophthalmic surgeries, boosting demand for precise and efficient equipment. Rising investments in ophthalmic research, product launches, and regulatory approvals also contribute to growth. Furthermore, expanding access to eye care services in emerging economies and the integration of digital diagnostics and real-time visualization tools are strengthening the long-term outlook of the retinal surgery device market.

Growth Drivers for the Retinal Surgery Device Market

Rapid Technological Advancements and Strategic Acquisitions

Technological innovation remains one of the most significant drivers of the retinal surgery device market. Next-generation vitrectomy systems, enhanced visualization platforms, and AI-supported diagnostics are transforming the precision and efficiency of retinal procedures. Companies continue to strengthen their portfolios through strategic acquisitions that accelerate product development and expand global presence. A key example is the April 2024 acquisition in which Carl Zeiss Meditec AG completed the purchase of the Dutch Ophthalmic Research Center. This move enhances its ophthalmic portfolio, workflow solutions, and innovation capabilities, supporting the development of more integrated surgical platforms. Such expansions enable manufacturers to offer comprehensive retinal care solutions, improving surgeon experience and patient outcomes. As global demand for advanced eye care rises, these technological improvements and corporate integrations fuel ongoing market growth.

Increased Adoption of Advanced Surgical Platforms and Approvals

A major growth factor for the retinal surgery device market is the rising adoption of advanced surgical platforms supported by regulatory approvals. Hospitals and ophthalmic centers increasingly depend on technologies that deliver higher precision, safer fluidics management, and improved visualization. In June 2024, Alcon received U.S. FDA 510(k) clearance for its Unity VCS and Unity CS systems, part of its next-generation Unity portfolio designed for cataract and vitreoretinal surgery. These platforms provide enhanced workflow efficiency and are expected to see wider commercialization beginning in 2025. Such approvals accelerate product uptake, helping healthcare facilities upgrade their surgical capabilities. As eye care providers strive to improve outcomes and shorten recovery time, the integration of advanced, regulatory-approved systems significantly boosts demand, strengthening the overall market trajectory.

Growing Focus on Minimally Invasive Ophthalmic Treatments

The shift toward minimally invasive retinal surgeries is another key driver, fueled by patient preference for faster recovery and lower postoperative complications. Surgeons increasingly rely on micro-incisional instruments, refined fluidics, and laser-based solutions to perform delicate retinal procedures with greater control. Strategic expansions by market leaders further promote innovation in minimally invasive techniques. In July 2024, Alcon announced the acquisition of Belkin Vision to expand its glaucoma treatment portfolio with direct selective laser trabeculoplasty (SLT). Since SLT is clinically effective and cost-efficient for managing open-angle glaucoma and ocular hypertension, this acquisition strengthens Alcon's capabilities in energy-based ophthalmic solutions. Such advancements in surgical technologies and glaucoma-retina care integration support wider adoption of minimally invasive procedures, driving robust market growth globally.

Challenges in the Retinal Surgery Device Market

High Cost of Advanced Ophthalmic Surgical Systems

One of the major obstacles to market expansion is the high cost associated with advanced retinal surgery devices. Modern vitrectomy units, high-resolution imaging tools, and laser platforms require significant capital investment, which can be prohibitive for smaller clinics or facilities in low-income regions. Additional expenses such as maintenance, consumables, and surgeon training further increase the financial burden. As a result, many healthcare centers delay adopting new technologies or continue using older equipment. Limited reimbursement coverage in some countries also restricts access to premium retinal treatment options. These financial constraints slow the pace of technology penetration, impacting the overall growth of the retinal surgery device market.

Shortage of Skilled Ophthalmic Surgeons

The retinal surgery device market faces challenges due to a global shortage of highly trained ophthalmic surgeons capable of performing complex retinal procedures. Retinal surgeries demand advanced microsurgical skills, extensive experience, and access to specialized training programs, which are not evenly distributed across regions. In developing countries, scarcity of fellowship programs and trained surgeons limits procedural volume and reduces demand for advanced surgical equipment. Even in developed markets, increasing patient loads and aging populations place pressure on available specialists. This shortage not only affects patient access to timely treatment but also slows the adoption of cutting-edge surgical technologies that require skilled professionals to maximize their benefits.

United States Retinal Surgery Device Market

The United States represents one of the most advanced markets for retinal surgery devices due to its strong healthcare infrastructure, high prevalence of retinal diseases, and rapid adoption of surgical innovations. Leading manufacturers frequently introduce new technologies and receive timely regulatory approvals, accelerating market penetration. The country benefits from a large base of trained ophthalmic surgeons and specialized eye care centers equipped with premium vitrectomy and imaging systems. Rising incidences of diabetes and age-related macular degeneration continue to drive procedural volume. Additionally, significant investment in clinical research, academic-industry collaboration, and reimbursement support strengthens the U.S. position as a key driver of global retinal surgery device demand.

Germany Retinal Surgery Device Market

Germany holds a strong position in the retinal surgery device market owing to its advanced medical infrastructure, high surgical standards, and early adoption of ophthalmic innovations. The country prioritizes precision, safety, and efficiency in retinal procedures, leading to steady demand for next-generation vitrectomy systems and imaging technologies. Strong collaboration between hospitals, research institutions, and device manufacturers supports constant innovation. Additionally, Germany's aging population has led to an increased incidence of retinal disorders such as macular degeneration, creating sustained demand for surgical interventions. Comprehensive insurance coverage and well-structured ophthalmology networks further enhance accessibility and support the rapid integration of advanced surgical devices.

China Retinal Surgery Device Market

China's retinal surgery device market is growing rapidly due to rising cases of diabetic retinopathy, expanding access to specialty eye care, and increasing investments in hospital modernization. The government continues to prioritize ophthalmic care, encouraging large-scale adoption of advanced surgical tools across new and upgraded facilities. China's fast-growing aging population also contributes to higher demand for retinal interventions. Local manufacturing capabilities are improving, while international companies strengthen their presence through partnerships and training programs. The expansion of private eye hospitals and growing awareness of early treatment further boost procedural volume. These factors collectively position China as one of the fastest-expanding markets globally.

Saudi Arabia Retinal Surgery Device Market

Saudi Arabia's market for retinal surgery devices is supported by increasing healthcare modernization, rising investment in ophthalmic centers, and a growing prevalence of diabetic eye diseases. The government's commitment to improving specialized medical services under Vision 2030 has accelerated the adoption of advanced retinal equipment, including vitrectomy systems, lasers, and imaging platforms. Many hospitals are expanding their ophthalmology departments and partnering with global manufacturers for training and technology integration. High diabetes rates contribute to elevated demand for retinal surgeries, while private-sector growth and medical tourism further enhance market opportunities. These developments make Saudi Arabia an emerging hub for advanced eye care in the Middle East.

Recent Developments in Retinal Surgery Device Market

  • February 2025: Optos introduced MonacoPro, its next-generation ultra-widefield and OCT retinal imaging platform. Building on the capabilities of the original Monaco system, MonacoPro delivers sharper OCT imaging, incorporates the new AreaAssist workflow tool, and features an expanded reference database. These enhancements are designed to support greater diagnostic accuracy and more efficient eye care workflows.
  • January 2025: Norlase secured both FDA 510(k) clearance and CE Mark approval for LYNX, a fully integrated pattern-scanning laser indirect ophthalmoscope. Engineered for a wide range of retinal treatments, LYNX increases portability and precision through wireless controls, advanced laser pattern options, and voice-activated operation, improving the flexibility and efficiency of retinal procedures
  • September 2024: ZEISS showcased a suite of new AI-enabled retinal care technologies at EURETINA 2024. Key innovations included the ARTEVO 850 3D visualization microscope, CIRRUS PathFinder AI for OCT interpretation, the EVA NEXUS surgical platform, and the Surgery Optimizer tool for procedural video analysis. Together, these systems elevate diagnostic capabilities and enhance surgical performance in retinal care.

Market Segmentation

Product

  • Vitrectomy Machines
  • Vitrectomy Packs
  • Surgical Instruments
  • Microscopic Illumination Equipment
  • Retinal Laser Equipment
  • Others

Application

  • Diabetic Retinopathy
  • Retinal Detachment
  • Epiretinal Membrane
  • Macular Hole
  • Others

End-Users

  • Hospitals
  • Eye Clinics
  • Others

Countries

North America

  • United States
  • Canada

Europe

  • France
  • Germany
  • Italy
  • Spain
  • United Kingdom
  • Belgium
  • Netherlands
  • Turkey

Asia Pacific

  • China
  • Japan
  • India
  • South Korea
  • Thailand
  • Malaysia
  • Indonesia
  • Australia
  • New Zealand

Latin America

  • Brazil
  • Mexico
  • Argentina

Middle East & Africa

  • Saudi Arabia
  • UAE
  • South Africa

All the Key players have been covered from 5 Viewpoints:

  • Overviews
  • Key Person
  • Recent Developments
  • SWOT Analysis
  • Revenue Analysis

Company Analysis:

  • Topcon Corporation
  • Alcon AG
  • Carl Zeiss
  • Bausch Health Companies Inc
  • Iridex Corporation
  • Escalon Medicals
  • Quantel Medical
  • Rhein Medical, Inc

Table of Contents

1. Introduction

2. Research & Methodology

  • 2.1 Data Source
    • 2.1.1 Primary Sources
    • 2.1.2 Secondary Sources
  • 2.2 Research Approach
    • 2.2.1 Top-Down Approach
    • 2.2.2 Bottom-Up Approach
  • 2.3 Forecast Projection Methodology

3. Executive Summary

4. Market Dynamics

  • 4.1 Growth Drivers
  • 4.2 Challenges

5. Global Retinal Surgery Devices Market

  • 5.1 Historical Market
  • 5.2 Market Forecast

6. Market Share Analysis

  • 6.1 By Product
  • 6.2 By Application
  • 6.3 By End User
  • 6.4 By Countries

7. Product

  • 7.1 Vitrectomy Machines
    • 7.1.1 Historical Market
    • 7.1.2 Market Forecast
  • 7.2 Vitrectomy Packs
    • 7.2.1 Historical Market
    • 7.2.2 Market Forecast
  • 7.3 Surgical Instruments
    • 7.3.1 Historical Market
    • 7.3.2 Market Forecast
  • 7.4 Microscopic Illumination Equipment
    • 7.4.1 Historical Market
    • 7.4.2 Market Forecast
  • 7.5 Retinal Laser Equipment
    • 7.5.1 Historical Market
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Historical Market
    • 7.6.2 Market Forecast

8. Application

  • 8.1 Diabetic Retinopathy
    • 8.1.1 Historical Market
    • 8.1.2 Market Forecast
  • 8.2 Retinal Detachment
    • 8.2.1 Historical Market
    • 8.2.2 Market Forecast
  • 8.3 Epiretinal Membrane
    • 8.3.1 Historical Market
    • 8.3.2 Market Forecast
  • 8.4 Macular Hole
    • 8.4.1 Historical Market
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Historical Market
    • 8.5.2 Market Forecast

9. End User

  • 9.1 Hospitals
    • 9.1.1 Historical Market
    • 9.1.2 Market Forecast
  • 9.2 Eye Clinics
    • 9.2.1 Historical Market
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Historical Market
    • 9.3.2 Market Forecast

10. Countries

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Historical Market
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Historical Market
      • 10.1.2.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 France
      • 10.2.1.1 Historical Market
      • 10.2.1.2 Market Forecast
    • 10.2.2 Germany
      • 10.2.2.1 Historical Market
      • 10.2.2.2 Market Forecast
    • 10.2.3 Italy
      • 10.2.3.1 Historical Market
      • 10.2.3.2 Market Forecast
    • 10.2.4 Spain
      • 10.2.4.1 Historical Market
      • 10.2.4.2 Market Forecast
    • 10.2.5 United Kingdom
      • 10.2.5.1 Historical Market
      • 10.2.5.2 Market Forecast
    • 10.2.6 Belgium
      • 10.2.6.1 Historical Market
      • 10.2.6.2 Market Forecast
    • 10.2.7 Netherlands
      • 10.2.7.1 Historical Market
      • 10.2.7.2 Market Forecast
    • 10.2.8 Turkey
      • 10.2.8.1 Historical Market
      • 10.2.8.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 China
      • 10.3.1.1 Historical Market
      • 10.3.1.2 Market Forecast
    • 10.3.2 Japan
      • 10.3.2.1 Historical Market
      • 10.3.2.2 Market Forecast
    • 10.3.3 India
      • 10.3.3.1 Historical Market
      • 10.3.3.2 Market Forecast
    • 10.3.4 Australia
      • 10.3.4.1 Historical Market
      • 10.3.4.2 Market Forecast
    • 10.3.5 South Korea
      • 10.3.5.1 Historical Market
      • 10.3.5.2 Market Forecast
    • 10.3.6 Thailand
      • 10.3.6.1 Historical Market
      • 10.3.6.2 Market Forecast
    • 10.3.7 Malaysia
      • 10.3.7.1 Historical Market
      • 10.3.7.2 Market Forecast
    • 10.3.8 Indonesia
      • 10.3.8.1 Historical Market
      • 10.3.8.2 Market Forecast
    • 10.3.9 New Zealand
      • 10.3.9.1 Historical Market
      • 10.3.9.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Historical Market
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Historical Market
      • 10.4.2.2 Market Forecast
    • 10.4.3 Argentina
      • 10.4.3.1 Historical Market
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East & Africa
    • 10.5.1 South Africa
      • 10.5.1.1 Historical Market
      • 10.5.1.2 Market Forecast
    • 10.5.2 Saudi Arabia
      • 10.5.2.1 Historical Market
      • 10.5.2.2 Market Forecast
    • 10.5.3 UAE
      • 10.5.3.1 Historical Market
      • 10.5.3.2 Market Forecast

11. Porter's Five Forces Analysis

  • 11.1 Bargaining Power of Buyers
  • 11.2 Bargaining Power of Suppliers
  • 11.3 Degree of Competition
  • 11.4 Threat of New Entrants
  • 11.5 Threat of Substitutes

12. SWOT Analysis

  • 12.1 Strength
  • 12.2 Weakness
  • 12.3 Opportunity
  • 12.4 Threats

13. Key Players Analysis

  • 13.1 Topcon Corporation
    • 13.1.1 Overviews
    • 13.1.2 Key Person
    • 13.1.3 Recent Developments
    • 13.1.4 SWOT Analysis
    • 13.1.5 Revenue Analysis
  • 13.2 Alcon AG
    • 13.2.1 Overviews
    • 13.2.2 Key Person
    • 13.2.3 Recent Developments
    • 13.2.4 SWOT Analysis
    • 13.2.5 Revenue Analysis
  • 13.3 Carl Zeiss
    • 13.3.1 Overviews
    • 13.3.2 Key Person
    • 13.3.3 Recent Developments
    • 13.3.4 SWOT Analysis
    • 13.3.5 Revenue Analysis
  • 13.4 Bausch Health Companies Inc
    • 13.4.1 Overviews
    • 13.4.2 Key Person
    • 13.4.3 Recent Developments
    • 13.4.4 SWOT Analysis
    • 13.4.5 Revenue Analysis
  • 13.5 Iridex Corporation
    • 13.5.1 Overviews
    • 13.5.2 Key Person
    • 13.5.3 Recent Developments
    • 13.5.4 SWOT Analysis
    • 13.5.5 Revenue Analysis
  • 13.6 Escalon Medicals
    • 13.6.1 Overviews
    • 13.6.2 Key Person
    • 13.6.3 Recent Developments
    • 13.6.4 SWOT Analysis
    • 13.6.5 Revenue Analysis
  • 13.7 Quantel Medical
    • 13.7.1 Overviews
    • 13.7.2 Key Person
    • 13.7.3 Recent Developments
    • 13.7.4 SWOT Analysis
    • 13.7.5 Revenue Analysis
  • 13.8 Rhein Medical, Inc
    • 13.8.1 Overviews
    • 13.8.2 Key Person
    • 13.8.3 Recent Developments
    • 13.8.4 SWOT Analysis
    • 13.8.5 Revenue Analysis